KEGG   DRUG: Bulevirtide acetate
Entry
D11878                      Drug                                   

Name
Bulevirtide acetate;
Hepcludex (TN)
Remark
Chemical structure group: DG03116
Efficacy
Antiviral, Entry inhibitor
  Disease
Hepatitis delta virus infection [DS:H00414]
Target
SLC10A1 (NTCP) [HSA:6554] [KO:K14341]
  Pathway
hsa05161  Hepatitis B
Brite
Target-based classification of drugs [BR:br08310]
 Transporters
  Solute carrier family
   SLC10
    SLC10A1 (NTCP)
     D11878  Bulevirtide acetate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11878
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11878
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system